An Analytical Reference Standard
Related Products
Unlabeled Version(s)
10012592Lacosamide
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Lacosamide-d3

Item No. 25426

Synonyms
Synonyms
  • Harkoseride-d3
Technical Information
Formal Name
2R-(acetylamino)-3-(methoxy-d3)-N-(phenylmethyl)-propanamide
CAS Number
1217689-95-6
Molecular Formula
C13H15D3N2O3
Formula Weight
Purity
≥99% deuterated forms (d1-d3)
A solid
Chloroform: SolubleMethanol: Soluble
SMILES
O=C([C@H](NC(C)=O)COC([2H])([2H])[2H])NCC1=CC=CC=C1
InChi Code
InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1/i2D3
InChi Key
VPPJLAIAVCUEMN-IBIJPGRPSA-N
Regulatory Information
DEA Schedule
V
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Cayman Spectral Library

    Our free, searchable, GC-MS spectral database contains 70eV EI mass spectral data of 2,000+ of Cayman’s forensic drug standards.

    DOWNLOAD THE DATABASE
    Product Description

    Lacosamide-d3 (Item No. 25426) is intended for use as an internal standard for the quantification of lacosamide (Item No. 10012592) by GC- or LC-MS. Lacosamide is categorized as an anticonvulsant.1,2,3 Formulations containing lacosamide have been used in the treatment of partial-onset and tonic-clonic seizures. Lacosamide-d3 is regulated as a Schedule V compound in the United States. This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Luszczki, J.J. Third-generation antiepileptic drugs: Mechanisms of action, pharmacokinetics and interactions. Pharmacol. Rep. 61(2), 197-216 (2009).

    2. Brandt, C., Heile, A., Potschka, H., et alEffects of the novel antiepileptic drug lacosamide on the dvelopment of amygdala kindling in rats. Epilepsia 47(11), (2006).

    3. Stöhr, T., Kupferberg, H.J., Stables, J.P., et alLacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy. Epilepsy Res. 74(2-3), 147-154 (2007).